DK156004C - Fremgangsmaade til stabilisering af prostacyclinforbindelser - Google Patents

Fremgangsmaade til stabilisering af prostacyclinforbindelser

Info

Publication number
DK156004C
DK156004C DK201879A DK201879A DK156004C DK 156004 C DK156004 C DK 156004C DK 201879 A DK201879 A DK 201879A DK 201879 A DK201879 A DK 201879A DK 156004 C DK156004 C DK 156004C
Authority
DK
Denmark
Prior art keywords
prostacycline
stabilizing
compounds
procedure
formulations
Prior art date
Application number
DK201879A
Other languages
Danish (da)
English (en)
Other versions
DK201879A (da
DK156004B (da
Inventor
Ian Seymour Watts
Peter Hugh Marsden
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK201879A publication Critical patent/DK201879A/da
Publication of DK156004B publication Critical patent/DK156004B/da
Application granted granted Critical
Publication of DK156004C publication Critical patent/DK156004C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK201879A 1978-05-17 1979-05-16 Fremgangsmaade til stabilisering af prostacyclinforbindelser DK156004C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2017578 1978-05-17
GB2017578 1978-05-17

Publications (3)

Publication Number Publication Date
DK201879A DK201879A (da) 1979-11-18
DK156004B DK156004B (da) 1989-06-12
DK156004C true DK156004C (da) 1989-11-06

Family

ID=10141640

Family Applications (1)

Application Number Title Priority Date Filing Date
DK201879A DK156004C (da) 1978-05-17 1979-05-16 Fremgangsmaade til stabilisering af prostacyclinforbindelser

Country Status (28)

Country Link
US (1) US4335139A (de)
EP (1) EP0005768B1 (de)
JP (1) JPS54163809A (de)
KR (1) KR830000527B1 (de)
AT (2) AT365926B (de)
AU (1) AU525695B2 (de)
BE (1) BE876296A (de)
CA (1) CA1141661A (de)
CH (1) CH641044A5 (de)
CS (1) CS214798B2 (de)
DE (2) DE2966046D1 (de)
DK (1) DK156004C (de)
ES (1) ES480597A1 (de)
FI (1) FI68359C (de)
FR (1) FR2425856A1 (de)
GR (1) GR68452B (de)
HU (1) HU182746B (de)
IL (1) IL57298A (de)
IT (1) IT1116840B (de)
LU (1) LU81272A1 (de)
MC (1) MC1265A1 (de)
NL (1) NL7903871A (de)
NZ (1) NZ190462A (de)
PH (1) PH15850A (de)
PL (1) PL134004B1 (de)
SE (1) SE450930B (de)
SU (1) SU978715A3 (de)
ZA (1) ZA787353B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010002A1 (de) * 1980-03-15 1981-10-01 Hoechst Ag, 6000 Frankfurt Prostaglandine enthaltende pharmazeutische zubereitung
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
KR0158870B1 (ko) * 1988-06-17 1998-12-01 마틴 에이. 로쓰블랫 폐순환 승압의 치료, 예방 또는 진단용 조성물
JP3421330B2 (ja) * 2000-11-02 2003-06-30 持田製薬株式会社 ビダラビン注射用乾燥製剤
EP1238670A1 (de) * 2001-03-07 2002-09-11 Bruce Daniels Zusammensetzungen zur Behandlung und Verhütung von Gefässerkrankungen und Hypertonie
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
DE602006005423D1 (de) * 2005-06-29 2009-04-16 Verisfield Uk Ltd Pharmazeutische Zusammensetzungen von Risperidon in wässriger Lösung
US8318802B2 (en) 2006-02-03 2012-11-27 Actelion Pharmaceuticals Ltd. Epoprostenol formulation and method of making thereof
CN103181893A (zh) 2007-09-07 2013-07-03 联合治疗公司 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法
HU231031B1 (hu) 2016-03-23 2019-12-30 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Megnövelt stabilitású epoprostenol nátrium és eljárás előállítására
DE202024100435U1 (de) 2023-02-14 2024-02-22 Tomasz Dąbrowski Zaunfeld zum Aufbau einer Reitbande

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036954A (en) 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
GB1504437A (en) 1974-03-08 1978-03-22 Dunlop Ltd Rubberplastics composites
DE2515001C2 (de) * 1975-04-04 1986-10-02 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin enthaltende gefriergetrocknete Pulver
US3997587A (en) 1975-06-26 1976-12-14 Syntex (U.S.A.) Inc. D1- and 8R-9-fluoro-prostadienoic acid derivatives
US4005133A (en) 1975-10-14 1977-01-25 The Upjohn Company PGF2.sub.α, L-Arginine salt
FR2351112A1 (fr) * 1975-10-21 1977-12-09 Wellcome Found Derive de prostaglandine et medicament contenant ce derive
US4062964A (en) 1975-12-03 1977-12-13 Ciba-Geigy Corporation Antifertility-combinations
GB1583961A (en) * 1976-05-11 1981-02-04 Wellcome Found Prostacyclin and derivatives thereof
JPS542335A (en) * 1977-05-20 1979-01-09 Wellcome Found Medical composition

Also Published As

Publication number Publication date
DK201879A (da) 1979-11-18
CA1141661A (en) 1983-02-22
FR2425856A1 (fr) 1979-12-14
CH641044A5 (de) 1984-02-15
ATE4411T1 (de) 1983-08-15
KR830000527B1 (ko) 1983-03-12
EP0005768B1 (de) 1983-08-10
AU525695B2 (en) 1982-11-25
DE2920020A1 (de) 1979-11-29
US4335139A (en) 1982-06-15
ZA787353B (en) 1980-08-27
SU978715A3 (ru) 1982-11-30
JPS54163809A (en) 1979-12-26
LU81272A1 (fr) 1979-12-07
CS214798B2 (en) 1982-05-28
PL215627A1 (de) 1981-08-07
FI68359C (fi) 1985-09-10
DE2920020C2 (de) 1988-09-01
BE876296A (fr) 1979-11-16
ES480597A1 (es) 1980-08-16
GR68452B (de) 1981-12-30
DE2966046D1 (en) 1983-09-15
SE7904284L (sv) 1979-11-18
JPS6358810B2 (de) 1988-11-17
HU182746B (en) 1984-03-28
NL7903871A (nl) 1979-11-20
IT7949064A0 (it) 1979-05-16
PL134004B1 (en) 1985-07-31
IL57298A0 (en) 1979-09-30
ATA363479A (de) 1981-07-15
PH15850A (en) 1983-04-13
IL57298A (en) 1983-09-30
MC1265A1 (fr) 1980-03-28
FR2425856B1 (de) 1982-06-25
AT365926B (de) 1982-02-25
SE450930B (sv) 1987-08-17
AU4704279A (en) 1979-11-22
NZ190462A (en) 1982-05-31
FI791565A (fi) 1979-11-18
IT1116840B (it) 1986-02-10
FI68359B (fi) 1985-05-31
DK156004B (da) 1989-06-12
EP0005768A1 (de) 1979-12-12

Similar Documents

Publication Publication Date Title
SE8700498D0 (sv) Novel pharmaceologically active compounds
DK372479A (da) Fremgangsmaade til fremstilling af aminosyrederivater
NO160850C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(bicykliske heterocyklyl)-4-piperidinaminer.
NO150106C (no) Anvendelse av en n-acyl-alfa-aminosyre som emulgeringsmiddel for fremstilling av emulsjoner
DK156004C (da) Fremgangsmaade til stabilisering af prostacyclinforbindelser
NO791205L (no) 2-(2-tenoyltio)-propionylglycin, fremgangsmaate for fremstilling derav og farmasoeytiske formuleringer som inneholder forbindelsen
DK125179A (da) Fremgangsmaade til fremstilling af disubstituerede 3-cephem-4-catboxylsyrederivater
NO921382D0 (no) Amidinofenylalaninderivater, samt fremstilling, anvendelse og preparater inneholdende forbindelsene
NO812556L (no) Fremgangsmaate for stabilisering av tienopyridinderivater
DK335279A (da) Fremgangsmaade til fremstilling af spirofuranohydantoin-forbindelser eller farmaceutisk acceptable metalsalte deraf
NO152649C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive fenylalkylaminer.
DK0521393T3 (da) Dichlofenac-cholinsalt, fremgangsmåde til fremstilling deraf og farmaceutiske præparater der indeholder det
DK66079A (da) Fremgangsmaade til fremstilling af detoxificerede praeparater af cytostatika
DK34888A (da) Fremgangsmaade til fremstilling af n,n-(dibenzohexatrienylen)urinstoffer
DK547279A (da) E fremgangsmaade til fremstilling af inaktiveret reovirusvaccin
DK319384A (da) 1-0-alkyl-3-amino-propan-1,2-diol-2-0-phospholipider, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
GB2021581A (en) Stabilisation of PGl2 derivatives
NO163327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydropyridiner.
DK154217C (da) Analogifremgangsmaade til fremstilling af 3-azetidinylaetyl-1-fenyl-2-imidazolidinonderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK34882A (da) Fremgangsmaade til fremstilling af peptidderivater
IT8722020A0 (it) Procedimento per la stabilizzazione di pellicole di polietilene.
DK409980A (da) Fremgangsmaade til fremstilling af aktivstofkombinationer indeholdende peptidderivater
IT7848889A0 (it) Composizione stabilizzante per vaccini
DK241783A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater

Legal Events

Date Code Title Description
PUP Patent expired